Anthem Biosciences IPO Review & Recommendations

Anthem Biosciences IPO Peer Comparison

Anthem Biosciences Ltd. peer comparison with similar listed entities. (As on March 28, 2025)

All the financial information for listed industry peers mentioned above is on a consolidated basis (unless otherwise available only on a standalone basis) and is sourced from the financial statements of the respective companies for the Fiscal ended March 31, 2025, submitted to stock exchanges*Financial information of the Company has been derived from the Restated Consolidated Financial Information.

Closing Price of Cohance Lifesciences Limited is as of July 7, 2025

Notes:

1. The P/E ratio for the listed industry peers has been computed based on the closing market price of equity shares on BSE Limited ("BSE") as on 18 December, 2024divided by the diluted earnings per share for the Fiscal ended March 31, 2024.
2. Return on Net Worth (%) = Ratio of Profit /(loss) for the year attributable to owners of the company for the Fiscal to NetWorth as of the last day of the relevant Fiscal. Net Worth means sum of equity share capital and other equity as of the last day of relevant fiscal and excludes non-controlling interest.
3. Net Asset Value per Equity Share = Net worth / Weighted average number of Equity Shares outstanding during the year. Net Worth means sum of equity share capital and other equity as of the last day of relevant fiscal and excludes non-controlling interest